Intellipharmaceutics International Inc. (IPCI)

[AngeloFoca]

But Woodcock also said that the agency sifted through the ANDA backlog and identified all of the first generics, or applications which offer a first wave of competition to their brand name counterparts, and that none of the applications left in the backlog are for such drugs.

This reinforces my belief that because of First Filer status on the 400 mg seroquel XR, Ipci will be ahead of the pack and get approval for the 400 and conditional approval for all other strengths - Other's approval may not come until who knows when.